News Daily News CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally Michael O'Riordan December 14, 2022
News Daily News Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements Michael O'Riordan December 07, 2022
News Daily News A Simple Nudge Moves the Needle on Statin Prescribing Michael O'Riordan December 02, 2022
News Conference News AHA 2022 Common ‘Heart’ Supplements Can’t Beat Statins: SPORT Michael O'Riordan November 06, 2022
News Conference News TCT 2022 Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus Yael L. Maxwell September 16, 2022
News Conference News ESC 2022 Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration Michael O'Riordan August 29, 2022
News Conference News ESC 2022 Polypill Bests Usual Care in Patients With Recent MI: SECURE Michael O'Riordan August 26, 2022
News Features Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD? Michael O'Riordan August 15, 2022
News Daily News Intermittent Fasting Trial Comes Out (Partly) Positive, but CV Impact Mixed Todd Neale August 12, 2022
News Daily News Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution Michael O'Riordan August 11, 2022
News Daily News USPSTF Recommends Behavior Counseling to Improve Diet and Exercise Habits Michael O'Riordan July 27, 2022
News Daily News Desperate for Relief, Long COVID Patients Seek Apheresis, Other Untested Therapies Todd Neale July 14, 2022
News Daily News Few Adults Eligible for Primary Prevention With Statins in Latest ESC Guidelines Michael O'Riordan July 06, 2022
News Daily News USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits Yael L. Maxwell June 23, 2022
News Conference News EAS 2022 Most Kids With FH Diagnosed by Cascade Screening, Albeit Late and Ineffectively Michael O'Riordan May 27, 2022
News Conference News EAS 2022 FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses Michael O'Riordan May 26, 2022
News Conference News EAS 2022 ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering Michael O'Riordan May 24, 2022
News Conference News EAS 2022 Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering Michael O'Riordan May 24, 2022
News Daily News Texting Tool Failed to Up Pill Adherence in ACS Patients: TEXTMEDS Caitlin E. Cox May 10, 2022
News Daily News Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV Michael O'Riordan May 09, 2022